Kangstem Biotech Co. Ltd Capital Reinvestment Ratio

Latest as of June 2019: 1.05x

Kangstem Biotech Co. Ltd capital reinvestment ratio. Kangstem Biotech Co. Ltd (217730) has a Capital Reinvestment Ratio of 1.05x as of June 2019, meaning it reinvests 1% of its operating cash flow (₩1.12 Billion) in capital expenditures (₩1.18 Billion). Check 217730 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

1.05x

Capex / Operating Cash Flow

Operating Cash Flow

₩1.12 Billion

KRW

Capital Expenditures

₩1.18 Billion

KRW

Data as of

Jun 2019

Most recent filing

Kangstem Biotech Co. Ltd Capital Reinvestment Ratio by Year (None–None)

Kangstem Biotech Co. Ltd capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Kangstem Biotech Co. Ltd cash flow conversion.

Year	Reinvestment Ratio	Operating CF (KRW)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow